Thyroid patients call the bluff

There's almost 4000 e-signatures so far on our federal petition, but hypothyroidism affects 3 to 5% of the Canadian population, and that's millions of people. So, it's time for a rant. It's time to rally the troops of well-educated thyroid patients and enlightened doctors. It's time to reason with the masses that blindly trust the … Continue reading Thyroid patients call the bluff

REVIEW: Ineffectiveness of L-T4 monotherapy in subclinical hypothyroidism

A new study published October 2018 has reviewed prior research on levothyroxine monotherapy in cases of "subclinical hypothyroidism" and has found it to be ineffective in improving quality of life and thyroid-related symptoms in patients. Studies like these could logically be used to launch a staunch critique against the presumed effectiveness of normalizing TSH via … Continue reading REVIEW: Ineffectiveness of L-T4 monotherapy in subclinical hypothyroidism

REVIEW: Autoimmune thyroid disease in Coeliac patients

A 2018 research study recruited 341 coeliac [celiac] disease patients and found that 91 of them (26.6%) had at least one autoimmune disease. Among those 91 patients, 44 patients (48.4%) also had a diagnosis of autoimmune thyroid disease. These coeliac patients with autoimmune thyroid disease constituted 12.9% of the total sample of 341 coeliac patients. … Continue reading REVIEW: Autoimmune thyroid disease in Coeliac patients

REVIEW: TSH does not enhance T3 levels in age

This 2016 research study discovered that TSH plays a role in enhancing T4-T3 conversion, but TSH is less able to enhance T3 levels after age 40. METHODS: Free T3, free T4, and TSH levels from 527, 564 sera collected from patients aged 1 year or greater were studied. ... 27,940 samples remaining after exclusion were stratified … Continue reading REVIEW: TSH does not enhance T3 levels in age

Infographic: The dangers of Low T3 Syndrome

Some research articles on Low T3 Syndrome Economidou, F., Douka, E., Tzanela, M., Nanas, S., & Kotanidou, A. (2011). Thyroid function during critical illness. Hormones (Athens, Greece), 10(2), 117–124. https://doi.org/10.14310/horm.2002.1301 The metabolic support of the critically ill patient is a relatively new target of active research and little is as yet known about the effects … Continue reading Infographic: The dangers of Low T3 Syndrome